Gearing Towards Successful Pharmaceutical Launch in Oman
We recently conducted an interview with Dr Mahmoud El Shabrawy, the General Manager of a... Read More
Guide to Successful Distributor and Manufacturer Relationships in the GCC
To enter the GCC market, international pharmaceutical and biotech companies are required to either establish... Read More
The Middle East: The Missed Market Opportunity
With a rapid marketing authorization process, the ability to achieve price parity with the US... Read More
The Evolving Biosimilar Policy Landscape in the Middle East
Biosimilar adoption level can vary depending on factors such as the specific healthcare systems, the... Read More
HTA Changes in MENA: What Does the Future Hold for New Product Launches in the Region?
There is growing interest in pharmacoeconomic principles across the Middle East and Africa region. The... Read More
Commercializing Innovations: Rethinking the Optimal Launch Strategy and Launch Sequencing
From the declining economic growth rate to the increase in inflation at a global level... Read More
ATMPs: Critical success drivers for the achievement of premium pricing in Saudi Arabia
The Saudi Arabian pharmaceutical market is regarded as one of the fastest growing in the... Read More
